App-Quantinova.ai

Persistent hypophosphataemia due to gastrointestinal losses

Rahat Tauni - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute renal failure

cholecalciferol

Evolution of glucose-insulin homeostasis in children with β - thalassemia major (β -TM): A twenty-year retrospective ICET- A observational analysis from early childhood to young adulthood

Vincenzo De Sanctis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Beta-thalassemia

N/A

Surrogate measures of insulin secretion and sensitivity (IS) in young children with beta thalassemia major on repeated blood transfusion and iron chelation therapy.

Vincenzo De Sanctis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Beta-thalassemia

N/A

Double Trouble. Metformin and empagliflozin induced lactic acidosis - A case report

Bhavna Sharma - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Type 2 diabetes mellitus

BI-10773

Sodium-glucose cotransporter-2 (SGLT-2) inhibitor-induced diabetic ketoacidosis and Fournier’s gangrene

Mona Abouzaid - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Diabetic ketoacidosis

BI-10773

Distinct inflammatory signatures of upper- and lower-body adipose tissue in postmenopausal women with normal weight and obesity

Ioannis Lempesis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Long-term safety of diazoxide choline extended-release (DCCR) tablets in patients with prader-willi syndrome

Evelien Gevers - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Prader-willi syndrome

Diazoxide

Bariatric Surgery in Type 1 Diabetes patients: a single centre study

Tanya Chopra - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

Insulinoma with Poland Syndrome

Suhail Ahmed - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hyperinsulinism

N/A

Quality improvement project; Recognition and management of Hyperosmolar Hyperglycemic State (HHS)

Adnan Adnan - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

N/A

Pegylated Interferon induced Latent Autoimmune Diabetes Mellitus of Adults(LADA) in acute setting is not uncommon

Gideon Mlawa - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

Pegylated interferon alpha

A personalised approach to tracking circulating cell free tumour derived DNA in a patient with adrenocortical carcinoma

Shailesh Gohil - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Adrenal carcinoma

N/A

Atypical presentation of recurrence following previous resected Primary Parathyroid Carcinoma- dilemmas in follow up of this rare malignancy

Haris Khan - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Adenocarcinoma of the rectum

cholecalciferol

Co-secretory ACTH & Calcitonin tumor presented with refractory hypokalemia

Bhavna Sharma - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronary Artery Disease

Magnesiocard

The development of a GLP protocol for the measurement of 17β-estradiol and testosterone in the H295R steroidogenesis assay, Test No 456

Carol Murray - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Alora

Epidemiological characteristics and psychological distress of well-controlled endocrine outpatients from Crete, Greece during the COVID-19 Pandemic: preliminary results of the EPITOME study.

Panagiotis-Nikolaos Tsakalomatis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Comparison of perceived sufficiency of information, sources of information, worries about the pandemic and psychological distress between endocrinology patients and staff at the outpatient department of the university hospital, heraklion, crete greece: preliminary results of the EPITOME study

Vasiliki Daraki - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Isolated ACTH deficiency with unusual clinical presentation and normal morning cortisol levels

Hassan Ibrahim - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Addison's disease

Hydrocortisone

Automated data extraction of structured clinical correspondence with SNOMED coding to assess regional epidemiology of common pituitary conditions

Shao Hao Alan Yap - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

hydrocortisone + gentamicin

Peak cortisol level on synacthen stimulation test in cushing’s disease

Razan Ali Rashid - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Cushing's syndrome

Tetracosactide

Filters

45280 Abstracts